Shared Investigator Platform

The Cognizant Shared Investigator Platform (SIP) is a pioneering SaaS-based clinical ecosystem designed to streamline clinical trials by connecting sponsors, sites, and technology providers. It offers a unified platform with a single sign-in, facilitating collaboration and document sharing across the clinical trial lifecycle.

In response to the pandemic and technological advancements like AI and remote collaboration, SIP supports a new approach to conducting clinical trials. It is the industry's first open platform that enables sponsors and sites to work together efficiently, reducing redundant tasks and accelerating study start-ups.

Key Features and Benefits

• Standardized Processes: SIP standardizes workflows, training, and documents, leading to improved efficiencies and faster time to market for new therapies.
• Global Reach: With over 300,000 users worldwide, SIP supports trials in emerging markets with adaptable safety protocols.
• Document Exchange: The SIP Document Exchange module ensures secure and efficient sharing of critical study documents, minimizing startup time.
• Safety Management: The SIP Safety Exchange module enhances efficiency and reduces administrative burdens, supporting scalability across regions.
• Integration and Collaboration: The eISF Connect module bridges sponsor eTMF systems with the Florence eISF system, addressing document exchange challenges.

SIP aligns with ICH E6(R3) guidelines to enhance participant safety, improve data quality, streamline operations, and ensure regulatory compliance. It empowers sites and sponsors to achieve readiness, resilience, and research excellence.

By eliminating inconsistencies and standardizing documents, SIP accelerates clinical trials, providing a better experience for clinical researchers and enabling virtual monitoring and study oversight. This platform is a strategic enabler for modern clinical trials, helping sponsors meet current challenges and improve trial efficiency.